Parkside Financial Bank & Trust’s SpringWorks Therapeutics SWTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-54	Closed	-$2.54K	–	2808
2025 Q2	$2.54K	Buy	54 +24	+80%	+$1.07K	﹤0.01%	1915
2025 Q1	$1.32K	Buy	+30	New	+$1.38K	﹤0.01%	2015

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parkside Financial Bank & Trust's SWTX Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 54 shares — an estimated $2.54K sold.

Parkside Financial Bank & Trust first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $2.54K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Parkside Financial Bank & Trust reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 54 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.54K.
Parkside Financial Bank & Trust first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Parkside Financial Bank & Trust's SpringWorks Therapeutics position peaked at $2.54K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.